196 related articles for article (PubMed ID: 24379587)
1. Metastatic type 1 gastric carcinoid: a real threat or just a myth?
Grozinsky-Glasberg S; Thomas D; Strosberg JR; Pape UF; Felder S; Tsolakis AV; Alexandraki KI; Fraenkel M; Saiegh L; Reissman P; Kaltsas G; Gross DJ
World J Gastroenterol; 2013 Dec; 19(46):8687-95. PubMed ID: 24379587
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.
Jung JH; Choi KD; Koh YW; Park YS; Jung HY; Lee GH; Song HJ; Kim DH; Choi KS; Lee JH; Ahn JY; Kim MY; Bae SE; Kim JH
Hepatogastroenterology; 2015; 62(137):207-13. PubMed ID: 25993755
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of patients with ECL cell-derived tumours.
Sagatun L; Fossmark R; Jianu CS; Qvigstad G; Nordrum IS; Mjønes P; Waldum HL
Scand J Gastroenterol; 2016 Nov; 51(11):1398-405. PubMed ID: 27309188
[TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
[TBL] [Abstract][Full Text] [Related]
7. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia.
Gough DB; Thompson GB; Crotty TB; Donohue JH; Kvols LK; Carney JA; Grant CS; Nagorney DM
World J Surg; 1994; 18(4):473-9; discussion 479-80. PubMed ID: 7725731
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.
Thomas D; Tsolakis AV; Grozinsky-Glasberg S; Fraenkel M; Alexandraki K; Sougioultzis S; Gross DJ; Kaltsas G
Eur J Endocrinol; 2013 Feb; 168(2):185-93. PubMed ID: 23132699
[TBL] [Abstract][Full Text] [Related]
9. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
11. Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.
Hung CY; Chen MJ; Shih SC; Liu TP; Chan YJ; Wang TE; Chang WH
World J Gastroenterol; 2008 Nov; 14(44):6884-7. PubMed ID: 19058321
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
13. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.
Eckhauser FE; Lloyd RV; Thompson NW; Raper SE; Vinik AI
Surgery; 1988 Dec; 104(6):1046-53. PubMed ID: 3194832
[TBL] [Abstract][Full Text] [Related]
14. Multiple gastric carcinoids associated with hypergastrinemia. A review of five cases with clinicopathological analysis and surgical strategies.
Okada K; Kijima H; Chino O; Matsuyama M; Okamoto Y; Yamamoto S; Tanaka M; Inokuchi S; Makuuchi H
Anticancer Res; 2005; 25(6C):4417-22. PubMed ID: 16334119
[TBL] [Abstract][Full Text] [Related]
15. Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature.
Spampatti MP; Massironi S; Rossi RE; Conte D; Sciola V; Ciafardini C; Ferrero S; Lodi L; Peracchi M
Eur J Gastroenterol Hepatol; 2012 May; 24(5):589-93. PubMed ID: 22465973
[TBL] [Abstract][Full Text] [Related]
16. Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature.
Xie SD; Wang LB; Song XY; Pan T
World J Gastroenterol; 2004 Aug; 10(16):2461-3. PubMed ID: 15285046
[TBL] [Abstract][Full Text] [Related]
17. Gastric carcinoids in patients with hypergastrinemia.
Jordan PH; Barroso A; Sweeney J
J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137
[TBL] [Abstract][Full Text] [Related]
18. Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
Elimova E; Ajani JA
J Clin Oncol; 2015 Oct; 33(28):3085-91. PubMed ID: 26324361
[TBL] [Abstract][Full Text] [Related]
19. Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Kawaguchi M; Asada Y; Terada T; Takehara A; Munemoto Y; Fujisawa K; Mitsui T; Iida Y; Miura S; Sudo Y
Int J Clin Oncol; 2010 Apr; 15(2):191-5. PubMed ID: 20179985
[TBL] [Abstract][Full Text] [Related]
20. Gastric enterochromaffin-like-cell tumor with liver and splenic metastases.
Eriguchi N; Aoyagi S; Hara M; Sakai T; Imayama H; Tanaka E; Hashimoto M; Imamura I; Kage M
J Gastroenterol; 1999 Jun; 34(3):383-6. PubMed ID: 10433017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
